CompletedPhase 2NCT00637572
Evaluate Weight Gain Using 2 Different Formulations of Megestrol Acetate Oral Suspension for AIDS-related Weight Loss
Studying AIDS wasting syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Endo Pharmaceuticals
- Principal Investigator
- Jan Fourie, MD58 Ann Street, Dundee, KZ-Natal 3000, S. Africa
- Intervention
- Megestrol acetate oral suspension nanocrystal dispersion 115 mg/mL(drug)
- Enrollment
- 63 enrolled
- Eligibility
- 18-70 years · All sexes
- Timeline
- 2004 – 2005
Study locations (12)
- Drexel University College of Medicine, Philadelphia, Pennsylvania, United States
- Victoria Hospital, Bangalore, Karnataka, India
- M.S. Ramaiah Medical College and Hospital, Bangalore, Karnataka, India
- Kasturba Medical College, Mangalore, Karnataka, India
- Ruby Hall Clinic and Grant Medical Foundation, Pune, Maharashtra, India
- St Mary's Hospital, Private Bag, Ashwood, South Africa
- Quinta-research, Pellissier, Bloemfontein, South Africa
- Genclin Corporation, Clinical Trial Centre, Westdene, Bloemfontein, South Africa
- 40 Arthur Hobbs Street, Boksburg, Johannesburg, South Africa
- 6 Calypso Centre, Richards Bay, KwaZulu-Natal, South Africa
- Eastmed Hospital, Eastlynn, Pretoria, South Africa
- TrialTech Clinical Research, Hatfield, Pretoria, South Africa
Collaborators
Quintiles, Inc.
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00637572 on ClinicalTrials.gov